Inactive Instrument

News Tibet Pharmaceuticals, Inc. Other OTC

Equities

Tibet Pharmaceuticals, Inc. announced a financing transaction	17-04-06	CI
Hong Yu, Chairman and Chief Executive Officer of TBET, cancelled the acquisition of the remaining 77.9% stake in Tibet Pharmaceuticals, Inc..	13-02-28	CI
Tibet Pharmaceuticals, Inc.(OTCPK:TBET) dropped from NASDAQ Composite Index	12-04-26	CI
Hong Yu, Chairman and Chief Executive Officer of TBET, signed a non-binding proposal letter to acquire the remaining 77.9% stake in Tibet Pharmaceuticals, Inc. for $34.7 million.	12-02-29	CI
Tibet Pharmaceuticals, Inc. Signs Letter of Intent to Cooperate with Anhui Taihe Pharmaceutical Group Co., Ltd	12-01-31	CI

No results for this search